ROZLYTREK HARD CAPSULE 100MG
Product details
Registration number: SIN16086P
Classification: Prescription Only
Active ingredients: Entrectinib (Form A) or (Form C)
Strength: 100.000mg
Dosage form: CAPSULE
Route: ORAL
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01XE56
HSA approval date: 27 January 2021
Manufacturer(s):
- Catalent Greenville, Inc.
- F. Hoffmann-La Roche Ltd (Primary and secondary packaging)
- Recipharm Leganés S.L.U.
Manufacturing country/countries: UNITED STATES; SWITZERLAND; SPAIN
What are the HSA registration number and classification for ROZLYTREK HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16086P
Classification: Prescription Only
What active ingredients and strength are recorded for ROZLYTREK HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Entrectinib (Form A) or (Form C)
Strength: 100.000mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ROZLYTREK HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for ROZLYTREK HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ROZLYTREK HARD CAPSULE 100MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Catalent Greenville, Inc.
- F. Hoffmann-La Roche Ltd (Primary and secondary packaging)
- Recipharm Leganés S.L.U.
Manufacturing country/countries: UNITED STATES; SWITZERLAND; SPAIN
Where can I look up ROZLYTREK HARD CAPSULE 100MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16086P or the exact product name ROZLYTREK HARD CAPSULE 100MG. The general register link does not preselect this product.
What are the source dates for this ROZLYTREK HARD CAPSULE 100MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ROZLYTREK HARD CAPSULE 100MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16086P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)